Αποτελέσματα Αναζήτησης
25 Ιουν 2020 · The burden of amputation is severe, with 5-year mortality rates exceeding those of many malignancies. Furthermore, caring for patients with PAD and diabetes mellitus imposes a significant cost to the healthcare system—estimated to range from $84 billion to $380 billion annually.
- View Epub
PK ™k«Xoa«, mimetypeapplication/epub+zipPK ™k«X...
- Pdf/Epub
PK • Woa«, mimetypeapplication/epub+zipPK • W...
- Diabetes Mellitus–Related All‐Cause and Cardiovascular Mortality in a National Cohort of Adults
We retrospectively studied 963 648 adults receiving care in...
- View Epub
1 Ιαν 2023 · IR of major amputations was 94.82 (95% CI 56.62–158.80) per 100,000 individuals with diabetes, among patients with type 1 diabetes was 100.76 (95% CI 53.71–189.01) and among type 2 diabetes was 40.58 (95% CI 11.03–149.28).
22 Ιουλ 2015 · For the full cohort of those with diabetes, the rate of death was 2.0% after 1 year of follow up and 7.3% after 5 years of follow up. In general, those with an LEA were more than three times more likely to die during a year of follow-up than an individual with diabetes who had not had an LEA.
1 Δεκ 2022 · Conclusions Globally, annual incidence of diabetes-related amputations from 2010 to 2020 has shown to disproportionately affect men and individuals with type 1 diabetes mellitus, although its...
High mortality rates have been reported after major amputations of a lower limb secondary to diabetes and peripheral vascular disease. However, the mortality rates have varied across studies. A systematic review of the 5-year mortality after nontraumatic major amputations of the lower extremity was conducted.
The mortality rate among people who have had diabetes-related amputations is an important issue that needs to be addressed through medical intervention, awareness, and legislation. The average life span after a full leg is amputated is roughly 5 years.
Globally, annual incidence of diabetes-related amputations from 2010 to 2020 has shown to disproportionately affect men and individuals with type 1 diabetes mellitus, although its incidence is not uniform across countries.
